Current Indications for Consideration of Evaluation for Hereditary Cancer Predisposition Syndromes and How They Can Change Management. Massingham LJ, De Souza A. R I Med J (2013). 2020 Apr 1;103(3):20-24. PMID: 32236156 PubMed abstract Review